Commercial
The Death Of The Brand
As pharma waves goodbye to brand-led strategies, how is this changing relationships with HCPs?
More Articles
Commercial
Surfing The Innovation Wave
With incredible innovation coming down the pike, pharma must do more to help health systems cope, says EFPIA’s Nathalie Moll
Commercial
Meet AI, The Doctor’s New Best Friend
AI insights will transform HCPs' practice in more ways than one, says Teva SVP Markus Leyck Dieken
Commercial
How Blockchain Will Help Pharma
Watch Richie Etwaru, Chief Digital Officer of IQVIA, below explain how blockchain, the technology behind bitcoin, can create a long-term trust improvement with pharmaceutical companies and their customers – but that we must understand the technology before it can be applied to clinical trials, contracting, approvals and more.
Commercial
Four Reasons Why Pharma Struggles To Engage HCPs Online (And How To Change That)
Pharma is failing to reach one of its critical customers in the online space, says Sanofi VP, Bozidar Jovicevic
Patients and Medical
Latin America: The Growing Pains Of Patient-Centricity
US and European markets are steering the ship on patient-centricity. But where is Latin America in this space?
Access and Evidence
Shifting Gears
McLaren has been a fixture of the Formula One circuit for half a century, but the company is now applying the technology it uses to monitor drivers and racing cars to solve health challenges
Commercial
Pharma’s Place in the Digital Space
Sanofi’s Chief Data Officer expounds the possibilities of digital and the role of the CDO in this burgeoning landscape
Access and Evidence
Artificial Intelligence: Friend Or Foe?
AI is fast becoming a reality. What does this mean for medical affairs?
Access and Evidence
Instant Feedback
Insights derived from “real-life” data are being billed as the next phase of pharma. But are payers convinced?